Pediatric Brain Tumors Market Size

Market Size in USD Bn

CAGR6.9%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	6.9%
Market Concentration	High
Major Players	Novartis, Pfizer, Bayer, Bristol-Myers Squibb, Eli Lilly and Company and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Pediatric Brain Tumors Market Analysis

The pediatric brain tumors market is estimated to be valued at USD 1.55 Bn in 2024 and is expected to reach USD 2.47 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031. Growing prevalence of pediatric brain cancers due to genetic risk factors and environmental exposures is driving the market. Rising healthcare spending for pediatric cancer treatment and development of advanced treatment options are also fueling the pediatric brain tumors market.